Zevra Therapeutics Inc (ZVRA)

SG&A Expense Growth

41.46%

Fiscal year · Period ending:

ZVRA logo

ZVRA SG&A Expense Growth

Latest reported41.46%
ZVRA FY SG&A Growth (YoY) (0.00% → 41.46%)
High-resolution chart · PNG

ZVRA sg&a expense growth history

Annual fiscal periods. Dates are reporting period ends; fiscal years can differ from calendar years.

Zevra Therapeutics Inc SG&A Expense Growth — Annual fiscal periods
Period endingSG&A Expense Growth
41.4595%
56.3681%
133.3355%
72.8307%
9.8472%
-26.7659%
-13.5273%
-2.0747%
-8.7643%
57.6044%
96.262%
235.018%
-42.3227%
0%
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.